Scientists evaluate the safety and efficacy outcomes of the most recent, placebo-controlled Phase I/II clinical studies that enrolled a larger number of patients, in order to provide a statistically relevant and comprehensive understanding of MSC’s therapeutic potential in severe COVID-19 patients.
[npj Regenerative Medicine]
Sorry, but the selected Zotpress account can't be found.
